Carlyle Nears Deal for J&J Unit - Presented by: The Aol. On Network

Carlyle has apparently won the showdown with archrival Blackstone Group over a blue blood. Sources tell Reuters it's close to a deal to buy Johnson & Johnson's blood testing business. It outbid Blackstone and its partner, Danaher, in an auction process. The deal could be worth around $4 billion. It's expected to be struck within two weeks.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.86 0.19 ▼ 1.11%
PBR $ 13.29 0.90 ▼ 6.34%
FB $ 76.32 2.72 ▼ 3.44%
F $ 14.6201 0.17 ▼ 1.15%
SIRI $ 3.425 0.07 ▼ 1.86%
QQQ $ 97.08 1.71 ▼ 1.73%
AAPL $ 98.9354 1.81 ▼ 1.80%
CSCO $ 25.065 0.11 ▼ 0.42%

As of 10/1/2014, 03:19 PM
More Most Active